Trinity Biotech Plc (TRIB) Return on Equity ROE from the fourth quarter 2025 to fourth quarter 2024 and annually, average high and low, overall ranking from Dec 31 2025 to Dec 31 2024 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Trinity Biotech Plc  (NASDAQ: TRIB)

Trinity Biotech Plc's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Trinity Biotech Plc in the fourth quarter 2025?
Due to the lack of equity, it was not possible to calculate Trinity Biotech Plc's return on equity (ROE) in its fourth quarter 2025

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Dec 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2024)
IV. Quarter
Y / Y Equity Change - - - - -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -37 -31 -31 -31 -31
Return On Equity (TTM) - - - - -
TRIB's Total Ranking # # # # #
Equity (TTM) in Millions -72 -72 -72 -72 -35
Seq. Equity Change - - - - -
Seq. Net Income Change - - - - -

Back to TRIB Management Effectiveness >> TRIB's 5 Years Annual ROE >> Compare TRIB ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Equity Statistics
High Average Low
0 %
0 %
0 %
 





TRIB Annual Return On Equity (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Equity in Millions -72 -35 -24 -2 0
Y / Y Equity Change - - - - -
Net Income in Millions -37 -31 -37 -44 -2
Y / Y Net Income Change - - - - -
Return On Equity - - - - -

Back to TRIB Management Effectiveness >> TRIB's 5 Years Annual ROE >> Compare TRIB ROE to its Competitors




More Return On Equity Ratios
In Vitro & In Vivo Diagnostic Substances Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
TRIB's' Return on Equity at Yahoo Finance
TRIB's Roe Ratio versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for TRIB's Competitors
Subscribers only: Roe for Trinity Biotech Plc's Suppliers
Subscribers only: Return On Equity for TRIB's Customers




Companies with similar Return On Equity at Dec 31 2025, within Healthcare Sector ROE
Check Cap Ltd  120.45 %
Medpace Holdings Inc   118.82 %
Tg Therapeutics Inc   101.12 %
Eli Lilly And Company  97.61 %
Amgen Inc   96.65 %
Halozyme Therapeutics Inc   92.67 %
Earth Science Tech Inc   82.09 %
Exelixis Inc   81.25 %
Elite Pharmaceuticals Inc   80.28 %
Zevra Therapeutics Inc   74.63 %
3m Company  71.32 %
Entera Bio Ltd   70.43 %
Aurinia Pharmaceuticals Inc   70.37 %
Idexx Laboratories Inc  69.78 %
Alnylam Pharmaceuticals Inc   69.25 %
Enlivex Therapeutics Ltd  63.85 %
Dariohealth Corp   59.48 %
Nrc Health  58.51 %
Zoetis Inc   56.31 %
Alpha Tau Medical Ltd  55.29 %
Transmedics Group Inc   53.88 %
Pulmatrix Inc   53.50 %
Abeona Therapeutics Inc   53.18 %
Novo Nordisk A  52.79 %
Medinotec Inc   52.76 %
Concentra Group Holdings Parent Inc   47.62 %
Theravance Biopharma inc   46.03 %
Galmed Pharmaceuticals Ltd   43.72 %
Acadia Pharmaceuticals Inc   41.90 %
Arrowhead Pharmaceuticals Inc   41.16 %

Date modified: 2026-07-07T13:58:52+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.